-
1
-
-
0036187210
-
Macrophages expressing the scavenger receptor CD163: A link between immune alterations of the gut and synovial inflammaton in spondyloarthropathy
-
DOI 10.1002/path.1044
-
Baeten D, Demetter P, Cuvelier CA, Kruithof E, Van Damme N, De Vos M, et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002; 196: 343-50. (Pubitemid 34189425)
-
(2002)
Journal of Pathology
, vol.196
, Issue.3
, pp. 343-350
-
-
Baeten, D.1
Demetter, P.2
Cuvelier, C.A.3
Kruithof, E.4
Van Damme, N.5
De Vos, M.6
Veys, E.M.7
De Keyser, F.8
-
2
-
-
2342555072
-
Association of CD163+ Macrophages and Local Production of Soluble CD163 with Decreased Lymphocyte Activation in Spondylarthropathy Synovitis
-
DOI 10.1002/art.20174
-
Baeten D, Moller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F,. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum 2004; 50: 1611-23. (Pubitemid 38608084)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.5
, pp. 1611-1623
-
-
Baeten, D.1
Moller, H.J.2
Delanghe, J.3
Veys, E.M.4
Moestrup, S.K.5
De Keyser, F.6
-
3
-
-
22244477842
-
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy
-
Baeten D, Kruithof E, De Rycke L, Boots AM, Mielants H, Veys EM, et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther 2005; 7: 359-69.
-
(2005)
Arthritis Res Ther
, vol.7
, pp. 359-369
-
-
Baeten, D.1
Kruithof, E.2
De Rycke, L.3
Boots, A.M.4
Mielants, H.5
Veys, E.M.6
-
4
-
-
65249143893
-
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis
-
Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, et al. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum 2009; 60: 966-75.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 966-975
-
-
Vandooren, B.1
Noordenbos, T.2
Ambarus, C.3
Krausz, S.4
Cantaert, T.5
Yeremenko, N.6
-
5
-
-
0034757676
-
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies
-
DOI 10.1002/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#
-
Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre G, et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001; 44: 2255-62. (Pubitemid 32977493)
-
(2001)
Arthritis and Rheumatism
, vol.44
, Issue.10
, pp. 2255-2262
-
-
Baeten, D.1
Peene, I.2
Union, A.3
Meheus, L.4
Sebbag, M.5
Serre, G.6
Veys, E.M.7
De Keyser, F.8
-
6
-
-
23644436874
-
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity
-
DOI 10.1002/art.21220
-
De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 2005; 52: 2323-30. (Pubitemid 41117416)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.8
, pp. 2323-2330
-
-
De Rycke, L.1
Nicholas, A.P.2
Cantaert, T.3
Kruithof, E.4
Echols, J.D.5
Vandekerckhove, B.6
Veys, E.M.7
De Keyser, F.8
Baeten, D.9
-
7
-
-
0038188762
-
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
-
Steenbakkers PG, Baeten D, Rovers E, Veys EM, Rijnders AW, Meijerink J, et al. Localization of MHC class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies. J Immunol 2003; 170: 5719-27. (Pubitemid 36617865)
-
(2003)
Journal of Immunology
, vol.170
, Issue.11
, pp. 5719-5727
-
-
Steenbakkers, P.G.A.1
Baeten, D.2
Rovers, E.3
Veys, E.M.4
Rijnders, A.W.M.5
Meijerink, J.6
De Keyser, F.7
Boots, A.M.H.8
-
8
-
-
1042278741
-
Detection of Major Histocompatibility Complex/Human Cartilage gp-39 Complexes in Rheumatoid Arthritis Synovitis as a Specific and Independent Histologic Marker
-
DOI 10.1002/art.20012
-
Baeten D, Steenbakkers PG, Rijnders AW, Boots AM, Veys EM, De Keyser F,. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. Arthritis Rheum 2004; 50: 444-51. (Pubitemid 38198828)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.2
, pp. 444-451
-
-
Baeten, D.1
Steenbakkers, P.G.A.2
Rijnders, A.M.W.3
Boots, A.M.4
Veys, E.M.5
De Keyser, F.6
-
9
-
-
67650021589
-
Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis
-
Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, et al. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheum 2009; 60: 1944-56.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 1944-1956
-
-
Cantaert, T.1
Brouard, S.2
Thurlings, R.M.3
Pallier, A.4
Salinas, G.F.5
Braud, C.6
-
10
-
-
71249158763
-
Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis
-
Lories RJ, Baeten DL,. Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27: S10-4.
-
(2009)
Clin Exp Rheumatol
, vol.27
-
-
Lories, R.J.1
Baeten, D.L.2
-
11
-
-
13944249962
-
Mast cells in the development of adaptive immune responses
-
DOI 10.1038/ni1158
-
Galli SJ, Nakae S, Tsai M,. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-42. (Pubitemid 40268194)
-
(2005)
Nature Immunology
, vol.6
, Issue.2
, pp. 135-142
-
-
Galli, S.J.1
Nakae, S.2
Tsai, M.3
-
12
-
-
0037464519
-
The mast cell in inflammatory arthritis
-
Wooley DE,. The mast cell in inflammatory arthritis. N Engl J Med 2003; 348: 1709-11.
-
(2003)
N Engl J Med
, vol.348
, pp. 1709-1711
-
-
Wooley, D.E.1
-
13
-
-
34248186535
-
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy
-
DOI 10.1111/j.1600-065X.2007.00504.x
-
Eklund KK,. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 2007; 217: 38-52. (Pubitemid 46718139)
-
(2007)
Immunological Reviews
, vol.217
, Issue.1
, pp. 38-52
-
-
Eklund, K.K.1
-
14
-
-
34248177826
-
Synovial mast cells: Role in acute and chronic arthritis
-
DOI 10.1111/j.1600-065X.2007.00506.x
-
Nigrovic PA, Lee DM,. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007; 217: 19-37. (Pubitemid 46718141)
-
(2007)
Immunological Reviews
, vol.217
, Issue.1
, pp. 19-37
-
-
Nigrovic, P.A.1
Lee, D.M.2
-
15
-
-
0037031680
-
Mast cells: A cellular link between autoantibodies and inflammatory arthritis
-
DOI 10.1126/science.1073176
-
Lee DM, Friend DS, Gurish MF, Benoist C, Matthis D, Brenner MB,. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297: 1689-92. (Pubitemid 35000781)
-
(2002)
Science
, vol.297
, Issue.5587
, pp. 1689-1692
-
-
Lee, D.M.1
Friend, D.S.2
Gurish, M.F.3
Benoist, C.4
Mathis, D.5
Brenner, M.B.6
-
16
-
-
33847238479
-
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
-
DOI 10.1073/pnas.0610852103
-
Nigrovic PA, Binstadt BA, Monach PA, Johnson A, Gurish M, Iwakura Y, et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci U S A 2007; 104: 2325-30. (Pubitemid 46391396)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.7
, pp. 2325-2330
-
-
Nigrovic, P.A.1
Binstadt, B.A.2
Monach, P.A.3
Johnsen, A.4
Gurish, M.5
Iwakura, Y.6
Benoist, C.7
Mathis, D.8
Lee, D.M.9
-
17
-
-
34347378283
-
Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-α, IL-1β and IL-1Ra
-
DOI 10.1007/s00011-007-6135-1
-
Sandler C, Lindstedt KA, Joutsiniemi S, Lappalainen J, Juutilainnen T, Kolah J, et al. Selective activation of mast cells in rheumatoid synovial tissue results in the production of TNF-α, IL-1β, and IL-1Ra. Inflamm Res 2007; 56: 230-9. (Pubitemid 47026291)
-
(2007)
Inflammation Research
, vol.56
, Issue.6
, pp. 230-239
-
-
Sandler, C.1
Lindstedt, K.A.2
Joutsiniemi, S.3
Lappalainen, J.4
Juutilainen, T.5
Kolah, J.6
Kovanen, P.T.7
Eklund, K.K.8
-
18
-
-
77951636478
-
Mast cells express IL-17A in rheumatoid arthritis synovium
-
Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, et al. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010; 184: 3336-40.
-
(2010)
J Immunol
, vol.184
, pp. 3336-3340
-
-
Hueber, A.J.1
Asquith, D.L.2
Miller, A.M.3
Reilly, J.4
Kerr, S.5
Leipe, J.6
-
19
-
-
61649100303
-
Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
-
Canete JD, Celis R, Noordenbos T, Moll C, Gomez-Puerta JA, Pizcueta P, et al. Distinct synovial immunopathology in Behçet disease and psoriatic arthritis. Arthritis Res Ther 2009; 11: R17.
-
(2009)
Arthritis Res Ther
, vol.11
-
-
Canete, J.D.1
Celis, R.2
Noordenbos, T.3
Moll, C.4
Gomez-Puerta, J.A.5
Pizcueta, P.6
-
20
-
-
0026003027
-
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
-
and the European Spondylarthropathy Study Group
-
Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al, and the European Spondylarthropathy Study Group. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1218-1227
-
-
Dougados, M.1
Van Der Linden, S.2
Juhlin, R.3
Huitfeldt, B.4
Amor, B.5
Calin, A.6
-
21
-
-
33746951437
-
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
-
DOI 10.1002/art.21972
-
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, and the CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73. (Pubitemid 44205029)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.8
, pp. 2665-2673
-
-
Taylor, W.1
Gladman, D.2
Helliwell, P.3
Marchesoni, A.4
Mease, P.5
Mielants, H.6
-
22
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
-
(1988)
Arthritis and Rheumatism
, vol.31
, Issue.3
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
Healey, L.A.7
Kaplan, S.R.8
Liang, M.H.9
Luthra, H.S.10
Medsger Jr., T.A.11
Mitchell, D.M.12
Neustadt, D.H.13
Pinals, R.S.14
Schaller, J.G.15
Sharp, J.T.16
Wilder, R.L.17
Hunder, G.G.18
-
23
-
-
0033396977
-
Needle arthroscopy of the knee with synovial biopsy sampling: Technical experience in 150 patients
-
DOI 10.1007/s100670050134
-
Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F,. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol 1999; 18: 434-41. (Pubitemid 30014161)
-
(1999)
Clinical Rheumatology
, vol.18
, Issue.6
, pp. 434-441
-
-
Baeten, D.1
Van Den Bosch, F.2
Elewaut, D.3
Stuer, A.4
Veys, E.M.5
De Keyser, F.6
-
24
-
-
20144371035
-
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
-
Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J, et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005; 7: R569-80.
-
(2005)
Arthritis Res Ther
, vol.7
-
-
Kruithof, E.1
Baeten, D.2
De Rycke, L.3
Vandooren, B.4
Foell, D.5
Roth, J.6
-
25
-
-
20844457463
-
Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: Comparison with other inflammatory arthropathies and correlation with outcome
-
Fonseca JE, Cortez-Dias N, Francisco A, Sobral M, Canhao H, Resende C, et al. Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: comparison with other inflammatory arthropathies and correlation with outcome. Clin Exp Rheumatol 2005; 23: 185-92. (Pubitemid 40662998)
-
(2005)
Clinical and Experimental Rheumatology
, vol.23
, Issue.2
, pp. 185-192
-
-
Fonseca, J.E.1
Cortez-Dias, N.2
Francisco, A.3
Sobral, M.4
Canhao, H.5
Resende, C.6
Castelao, W.7
Macieira, C.8
Sequeira, G.9
Saraiva, F.10
Pereira Da Silva, J.A.11
Carmo-Fonseca, M.12
Queiroz, M.V.13
-
26
-
-
51649123035
-
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
-
Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008; 112: 1269-79.
-
(2008)
Blood
, vol.112
, pp. 1269-1279
-
-
Huang, B.1
Lei, Z.2
Zhang, G.M.3
Li, D.4
Song, C.5
Li, B.6
-
27
-
-
36849085429
-
Regulation of mast cell development by inflammatory factors
-
DOI 10.2174/092986707782793998
-
Hu ZQ, Zhoa WH, Shimamura T,. Regulation of mast cell development by inflammatory factors. Curr Med Chem 2007; 14: 3044-50. (Pubitemid 350226973)
-
(2007)
Current Medicinal Chemistry
, vol.14
, Issue.28
, pp. 3044-3050
-
-
Hu, Z.-Q.1
Zhao, W.-H.2
Shimamura, T.3
-
28
-
-
34848886843
-
The ST2 ligand IL-33 potently activates and drives maturation of human mast cells
-
Allakhverdi Z, Smith DE, Comeau MR, Delespesse G,. The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007; 179: 2051-4.
-
(2007)
J Immunol
, vol.179
, pp. 2051-2054
-
-
Allakhverdi, Z.1
Smith, D.E.2
Comeau, M.R.3
Delespesse, G.4
-
29
-
-
49449111630
-
IL-33 exacerbates antigen-induced arthritis by activating mast cells
-
Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 2008; 105: 10913-8.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 10913-10918
-
-
Xu, D.1
Jiang, H.R.2
Kewin, P.3
Li, Y.4
Mu, R.5
Fraser, A.R.6
-
30
-
-
79958798030
-
The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis
-
[abstract]
-
Baeten D, Sieper J, Emery P, Braun J, van der Heijde D, McInnes I, et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis [abstract]. Arthritis Rheum 2010; 62: 3840-1.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 3840-3841
-
-
Baeten, D.1
Sieper, J.2
Emery, P.3
Braun, J.4
Van Der Heijde, D.5
McInnes, I.6
-
31
-
-
23444462473
-
Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: A potential approach to the treatment of arthritis
-
DOI 10.1136/ard.2004.029835
-
Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen MJ, et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis 2005; 64: 1126-31. (Pubitemid 41113344)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.8
, pp. 1126-1131
-
-
Juurikivi, A.1
Sandler, C.2
Lindstedt, K.A.3
Kovanen, P.T.4
Juutilainen, T.5
Leskinen, M.J.6
Maki, T.7
Eklund, K.K.8
-
32
-
-
0035150659
-
Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: Histologic findings in eight patients from an open-label pilot study
-
DOI 10.1002/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B
-
Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, Cuvelier C, et al. Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 2001; 44: 186-95. (Pubitemid 32113134)
-
(2001)
Arthritis and Rheumatism
, vol.44
, Issue.1
, pp. 186-195
-
-
Baeten, D.1
Kruithof, E.2
Van Bosch, F.D.3
Demetter, P.4
Van Damme, N.5
Cuvelier, C.6
De Vos, M.7
Mielants, H.8
Veys, E.M.9
De Keyser, F.10
-
33
-
-
16344381733
-
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy
-
DOI 10.1136/ard.2003.018549
-
Kruithof E, Baeten D, Van den Bosch F, Mielants H, Veys EM, De Keyser F,. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy. Ann Rheum Dis 2005; 64: 529-36. (Pubitemid 40469080)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.4
, pp. 529-536
-
-
Kruithof, E.1
Baeten, D.2
Van Den Bosch, F.3
Mielants, H.4
Veys, E.5
De Keyser, F.6
-
34
-
-
29144437814
-
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies
-
DOI 10.1002/art.21426
-
Kruithof E, De Rycke L, Roth J, Mielants H, Van den Bosch F, De Keyser F, et al. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. Arthritis Rheum 2005; 52: 3898-909. (Pubitemid 41798229)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.12
, pp. 3898-3909
-
-
Kruithof, E.1
De Rycke, L.2
Roth, J.3
Mielants, H.4
Van Den Bosch, F.5
De Keyser, F.6
Veys, E.M.7
Baeten, D.8
-
35
-
-
0034046229
-
Tumor necrosis factor α promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis
-
DOI 10.1002/1529-0131(200001)43:1<164::AID-ANR21>3.0.CO;2-Z
-
Kiener HP, Hofbauer R, Tohidast-Akrad M, Walchshofer S, Redlich K, Bitzan P, et al. Tumor necrosis factor α promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis. Arthritis Rheum 2000; 43: 164-74. (Pubitemid 30368226)
-
(2000)
Arthritis and Rheumatism
, vol.43
, Issue.1
, pp. 164-174
-
-
Kiener, H.P.1
Hofbauer, R.2
Tohidast-Akrad, M.3
Walchshofer, S.4
Redlich, K.5
Bitzan, P.6
Kapiotis, S.7
Steiner, G.8
Smolen, J.S.9
Valent, P.10
-
36
-
-
40549088214
-
The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation
-
DOI 10.1002/art.23290
-
Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D,. The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum 2008; 58: 718-29. (Pubitemid 351364869)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.3
, pp. 718-729
-
-
Vandooren, B.1
Cantaert, T.2
Noordenbos, T.3
Tak, P.P.4
Baeten, D.5
-
37
-
-
54949094677
-
Tumor necrosis factor α drives cadherin 11 expression in rheumatoid inflammation
-
Vandooren B, Cantaert T, ter Borg M, Noordenbos T, Kuhlman R, Gerlag D, et al. Tumor necrosis factor α drives cadherin 11 expression in rheumatoid inflammation. Arthritis Rheum 2008; 58: 3051-62.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 3051-3062
-
-
Vandooren, B.1
Cantaert, T.2
Ter Borg, M.3
Noordenbos, T.4
Kuhlman, R.5
Gerlag, D.6
-
38
-
-
0036085728
-
Mast cells and angiogenesis
-
Norrby K,. Mast cells and angiogenesis. APMIS 2002; 110: 355-71.
-
(2002)
APMIS
, vol.110
, pp. 355-371
-
-
Norrby, K.1
-
39
-
-
0034467018
-
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion
-
DOI 10.1186/ar70
-
Woolley DE, Tetlow IC,. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2000; 2: 65-74. (Pubitemid 32223702)
-
(2000)
Arthritis Research
, vol.2
, Issue.1
, pp. 65-74
-
-
Woolley, D.E.1
Tetlow, L.C.2
-
40
-
-
34248137929
-
Differential release of mast cell mediators and the pathogenesis of inflammation
-
DOI 10.1111/j.1600-065X.2007.00519.x
-
Theoharides TC, Kempurai D, Tagen M, Conti P, Kalogeromitros D,. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007; 217: 65-78. (Pubitemid 46718152)
-
(2007)
Immunological Reviews
, vol.217
, Issue.1
, pp. 65-78
-
-
Theoharides, T.C.1
Kempuraj, D.2
Tagen, M.3
Conti, P.4
Kalogeromitros, D.5
-
41
-
-
78649569553
-
TLR-mediated signalling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release
-
Smrz D, Iwaki S, McVicar DW, Metcalfe DD, Gilfillan AM,. TLR-mediated signalling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release. Eur J Immunol 2010; 40: 2557-69.
-
(2010)
Eur J Immunol
, vol.40
, pp. 2557-2569
-
-
Smrz, D.1
Iwaki, S.2
McVicar, D.W.3
Metcalfe, D.D.4
Gilfillan, A.M.5
-
42
-
-
79951962451
-
Human cord blood-derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines
-
Enoksson M, Ejendal KF, McAlpine S, Nilsson G, Lunderius-Andersson C,. Human cord blood-derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines. J Innate Immun 2011; 3: 142-9.
-
(2011)
J Innate Immun
, vol.3
, pp. 142-149
-
-
Enoksson, M.1
Ejendal, K.F.2
McAlpine, S.3
Nilsson, G.4
Lunderius-Andersson, C.5
-
43
-
-
78649666553
-
Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis
-
Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PloS One 2010; 5: e14108.
-
(2010)
PloS One
, vol.5
-
-
Res, P.C.1
Piskin, G.2
De Boer, O.J.3
Van Der Loos, C.M.4
Teeling, P.5
Bos, J.D.6
-
44
-
-
76749088486
-
Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques
-
De Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, Idu MM, van Maldegem F, et al. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol 2010; 220: 499-508.
-
(2010)
J Pathol
, vol.220
, pp. 499-508
-
-
De Boer, O.J.1
Van Der Meer, J.J.2
Teeling, P.3
Van Der Loos, C.M.4
Idu, M.M.5
Van Maldegem, F.6
-
45
-
-
47049123836
-
The interleukin-23/interleukin-17 axis in spondyloarthritis
-
Layh-Schmitt G, Colbert RA,. The interleukin-23/interleukin-17 axis in spondyloarthritis. Curr Opin Rheumatol 2008; 20: 392-7.
-
(2008)
Curr Opin Rheumatol
, vol.20
, pp. 392-397
-
-
Layh-Schmitt, G.1
Colbert, R.A.2
-
46
-
-
0021991477
-
Inhibition of IgE-mediated mast cell degranulation by sulphasalazine
-
DOI 10.1016/0014-2999(85)90071-8
-
Barrett KE, Tashof TL, Metcalfe DD,. Inhibition of IgE-mediated mast cell degranulation by sulphasalazine. Eur J Pharmacol 1985; 107: 279-81. (Pubitemid 15153326)
-
(1985)
European Journal of Pharmacology
, vol.107
, Issue.2
, pp. 279-281
-
-
Barrett, K.E.1
Tashof, T.L.2
Metcalfe, D.D.3
-
47
-
-
0030028383
-
Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells
-
Bissonnette EY, Enciso JA, Befus AD,. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells. J Immunol 1996; 156: 218-23. (Pubitemid 26006966)
-
(1996)
Journal of Immunology
, vol.156
, Issue.1
, pp. 218-223
-
-
Bissonnette, E.Y.1
Enciso, J.A.2
Befus, A.D.3
-
48
-
-
17044403497
-
Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib
-
Dewar AL, Cambareri AC, Zannettino AC, Miller BL, Doherty KV, Hughes TP, et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 2005; 105: 3127-32.
-
(2005)
Blood
, vol.105
, pp. 3127-3132
-
-
Dewar, A.L.1
Cambareri, A.C.2
Zannettino, A.C.3
Miller, B.L.4
Doherty, K.V.5
Hughes, T.P.6
-
49
-
-
33745753403
-
Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts
-
DOI 10.1016/j.bbrc.2006.06.052, PII S0006291X06013040
-
Sandler C, Joutsiniemi S, Lindstedt KA, Juutilainen T, Kovanen PT, Eklund KK,. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2006; 347: 31-5. (Pubitemid 44015645)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.347
, Issue.1
, pp. 31-35
-
-
Sandler, C.1
Joutsiniemi, S.2
Lindstedt, K.A.3
Juutilainen, T.4
Kovanen, P.T.5
Eklund, K.K.6
-
50
-
-
33751408283
-
Three months treatment of active spondyloarthritis with imatinib mesylate: An open-label pilot study with six patients [3]
-
DOI 10.1093/rheumatology/kel365
-
Eklund KK, Remitz A, Kautiainen H, Reitamo S, Leirisalo-Repo M,. Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients. Rheumatology (Oxford) 2006; 45: 1573-5. (Pubitemid 44817070)
-
(2006)
Rheumatology
, vol.45
, Issue.12
, pp. 1573-1575
-
-
Eklund, K.K.1
Remitz, A.2
Kautiainen, H.3
Reitamo, S.4
Leirisalo-Repo, M.5
|